A detailed history of Groupama Asset Managment transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Groupama Asset Managment holds 54,507 shares of RDY stock, worth $788,716. This represents 0.01% of its overall portfolio holdings.

Number of Shares
54,507
Previous 53,559 1.77%
Holding current value
$788,716
Previous $707 Million 16.19%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$12.36 - $16.17 $11,717 - $15,329
948 Added 1.77%
54,507 $821 Million
Q1 2025

May 14, 2025

BUY
$12.53 - $15.81 $671,094 - $846,767
53,559 New
53,559 $707 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.4B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.